[1] |
Anderson L,Brown JP,Clark AM,et al.Patient education in the management of coronary heart disease[J]. Cochrane database Syst Rev,2017,6:CD008895. doi:10.1002/14651858.
|
[2] |
Wang L, Ai D, Zhang N. Exercise benefits coronary heart disease[J]. Adv Exp Med Biol,2017,1000:3-7.
|
[3] |
Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies[J]. Cardiovasc Hematol Agents Med Chem,2017,14:150-159.
|
[4] |
Dong Y, Chen H, Gao J, et al. Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease[J]. J Mol Cell Cardiol, 2019,136:27-41.
|
[5] |
Al-Kuraishy HM, Al-Gareeb AI. Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins[J]. J Lab Physicians, 2017,9:163-169.
|
[6] |
Cianflone K. Acylation stimulating protein and the adipocyte[J]. J Endocrinol,1997,155:203-206.
|
[7] |
Maslowska M, Legakis H, Assadi F,et al. Targeting the signaling pathway of acylation stimulating protein[J]. J Lipid Res, 2006,47:643-652.
|
[8] |
闻颖,吴巧玲,刘国利.舒芬太尼后处理通过ERK1/2介导的p70S6K信号通路对大鼠心肌缺血再灌注损伤的保护作用[J].吉林大学学报(医学版),2020,46:792-797.
|
[9] |
O'Rourke RW. Adipose tissue and the physiologic underpinnings of metabolic disease[J]. Surg Obes Relat Dis, 2018,14:1755-1763.
|
[10] |
MacLaren R, Cui W, Cianflone K. Adipokines and the immune system: an adipocentric view[J].Adv Exp Med Biol,2008,632:1-21.
|
[11] |
Onat A, Can G, Rezvani R, et al. Complement C3 and cleavage products in cardiometabolic risk[J]. Clin Chim Acta, 2011,412:1171-1179.
|